N/A N=94 Randomized Supportive Care

Opioid Sparing Potential of Light-Induced Analgesia

Pain

Bottom Line

View on ClinicalTrials.gov: NCT03890419 ↗

Enrolled (actual)

Serious AEs

0.0%

Results posted

Oct 2021

Primary outcome: Primary: Change in Pain Level — 1.15; -0.04; 1.07 score on a scale

Study Design & Population

Study type: Interventional
Phase: N/A
Interventions: Green light (Device); Clear light (Device); Blue Light (Device)
Age: Adult, Older Adult · 18+ yrs
Sex: All
Sponsor: Duke University
Primary completion: Mar 2021

Outcome Measures

Outcome	Result	p-value
PRIMARY Change in Pain Level	1.15; -0.04; 1.07	—
PRIMARY Change in Opioid Dose Used for Pain	37.36; 37.38; 56.20	—

Summary

This is a pilot trial testing the potential opioid-sparing analgesic effect of a novel non-pharmacological treatment using visualized light spectrums. Preclinical findings have shown such treatments to alter pain perception.

Eligibility Criteria

Inclusion Criteria

Scheduled for thoracic surgery for which post-operative opioid PCA is anticipated (Acute Pain group) OR currently treated with opioid therapy for fibromyalgia (Chronic Pain group)
18 years of age and older
Able to wear study eyeglasses for at least 4 hours per day
Agree to participate and provide written informed consent and HIPAA authorization

Exclusion Criteria

None

View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03890419). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.